GKOS
GLAUKOS CorpCompany Information
- Company Name
- GLAUKOS Corp
- CIK
- CIK0001192448
- Category
- Large accelerated filer
- Ticker: Exchange
- GKOS: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- GKOS
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-25
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 437,748
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 59,536,395
- Shares outstanding
- 58,818,000
- Ownership
- 101.22%
Earnings Market Reaction
- Filing date
- 2026-07-29
- Price on filing date
- —
- 1-month reaction
- 14.37%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 114 | 104 | 91 | 98 | 101 | 114 | 170 | 100 | 68 | 42 | 93 | 109 | ||||||
| Available For Sale Securities Debt Securities | 172 | 172 | 188 | 175 | 174 | 184 | 149 | 162 | 194 | 230 | 202 | 192 | ||||||
| Accounts Receivable Net Current | 139 | 120 | 109 | 99 | 83 | 72 | 61 | 56 | 51 | 47 | 40 | 39 | ||||||
| Inventory Net | 59 | 62 | 64 | 64 | 65 | 59 | 58 | 60 | 56 | 50 | 42 | 40 | ||||||
| Prepaid Expense And Other Assets Current | 31 | 27 | 24 | 19 | 14 | 15 | 12 | 19 | 14 | 19 | 18 | 20 | ||||||
| Assets Current | 516 | 486 | 475 | 455 | 436 | 445 | 450 | 397 | 384 | 389 | 395 | 400 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | ||||||
| Property Plant And Equipment Net | 112 | 112 | 113 | 111 | 112 | 97 | 98 | 99 | 100 | 102 | 103 | 103 | ||||||
| Operating Lease Right Of Use Asset | 31 | 31 | 32 | 32 | 32 | 32 | 30 | 27 | 26 | 27 | 27 | 27 | ||||||
| Finance Lease Right Of Use Asset | 38 | 39 | 39 | 40 | 41 | 41 | 42 | 42 | 43 | 44 | 44 | 45 | ||||||
| Intangible Assets Net Excluding Goodwill | 127 | 133 | 142 | 264 | 270 | 258 | 263 | 269 | 276 | 282 | 283 | 289 | ||||||
| Goodwill | 67 | 67 | 67 | 67 | 67 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | ||||||
| Assets | 921 | 893 | 893 | 999 | 987 | 966 | 975 | 927 | 920 | 933 | 940 | 949 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 19 | 19 | 25 | 20 | 14 | 16 | 13 | 11 | 12 | 13 | 13 | 10 | ||||||
| Accrued Liabilities Current | 83 | 70 | 77 | 68 | 65 | 53 | 62 | 61 | 59 | 59 | 61 | 57 | ||||||
| Liabilities Current | 102 | 89 | 101 | 88 | 79 | 69 | 75 | 72 | 70 | 72 | 74 | 67 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | 57 | 57 | 283 | 283 | 282 | ||||||
| Operating Lease Liability Noncurrent | 35 | 35 | 36 | 36 | 36 | 36 | 34 | 31 | 30 | 30 | 30 | 31 | ||||||
| Finance Lease Liability Noncurrent | 67 | 68 | 68 | 68 | 69 | 69 | 69 | 70 | 70 | 70 | 71 | 71 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Other Liabilities Noncurrent | 32 | 29 | 32 | 31 | 31 | 21 | 22 | 22 | 21 | 20 | 14 | 13 | ||||||
| Liabilities | 238 | 222 | 237 | 230 | 222 | 202 | 208 | 258 | 255 | 483 | 479 | 471 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,651 | 1,621 | 1,586 | 1,566 | 1,546 | 1,525 | 1,510 | 1,378 | 1,353 | 1,089 | 1,060 | 1,039 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -971 | -953 | -933 | -799 | -783 | -764 | -745 | -712 | -690 | -640 | -599 | -562 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | 682 | 671 | 656 | 770 | 765 | 764 | 767 | 669 | 665 | 451 | 462 | 478 | ||||||
| Liabilities And Stockholders Equity | 921 | 893 | 893 | 999 | 987 | 966 | 975 | 927 | 920 | 933 | 940 | 949 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 59 | 58 | 58 | 57 | 57 | 57 | 56 | 55 | 55 | 50 | 49 | 49 | ||||||
| Shares Outstanding | 59 | 58 | 58 | 57 | 57 | 57 | 56 | 55 | 55 | 50 | 49 | 49 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGLAUKOS Corp (GKOS) — SEC Financial Statements & Analysis
GLAUKOS Corp (GKOS) is a surgical & medical instruments & apparatus company, incorporated in DE. GLAUKOS Corp trades on NYSE as: GKOS. GLAUKOS Corp (GKOS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, GLAUKOS Corp carries a market cap of $8.22B, a P/E ratio of -43.71x, a P/B ratio of 12.04x, a P/S ratio of 13.41x, an enterprise value of $8.17B, and an EV/EBITDA multiple of -44.92x. On profitability, it posts a gross margin of 60.70%, an operating margin of -31.55%, a net margin of -30.68%, a Return on Equity (ROE) of -25.98%, a Return on Assets (ROA) of -19.72%, and a Return on Invested Capital (ROIC) of -27.28%. Per share, it reports EPS of $-3.20, diluted EPS of $-3.20, free cash flow per share of $-0.21, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 41.55% year-over-year, net income growth of 102.66% year-over-year, and EPS growth of 97.10% year-over-year. On the balance sheet, it maintains a current ratio of 5.04x, a quick ratio of 4.15x, working capital of $413.45M, a debt-to-equity ratio of 0.35x, a debt ratio of 0.26, an interest coverage ratio of -39.42x, free cash flow of $-12.20M (TTM), and net debt of $-50.26M. Figures sourced from SEC EDGAR.
- Market Cap
- $8.22B
- P/E TTM
- -43.71x
- EPS TTM
- $-3.20
- P/B TTM
- 12.04x
- ROE TTM
- -25.98%
- ROA TTM
- -19.72%
- Debt To Equity
- 0.35x
- Free Cash Flow TTM
- $-12.20M
- Net Revenue TTM Growth 1Y
- 41.55%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GLAUKOS Corp in?
GLAUKOS Corp (GKOS) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does GKOS trade on?
GLAUKOS Corp (GKOS) trades on the NYSE.
Where is GLAUKOS Corp incorporated?
GLAUKOS Corp is incorporated in DE.
When was GLAUKOS Corp (GKOS)'s most recent SEC filing?
GLAUKOS Corp (GKOS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.
What is GKOS's market cap?
GLAUKOS Corp (GKOS) has a market capitalization of $8.22B as of 2026-06-30.
What is GKOS's EPS (earnings per share)?
GLAUKOS Corp (GKOS)'s trailing twelve month EPS is $-3.20 as of 2026-06-30.
What is GKOS's ROE (return on equity)?
GLAUKOS Corp (GKOS)'s trailing twelve month Return on Equity (ROE) is -25.98% as of 2026-06-30.
What is GKOS's ROA (return on assets)?
GLAUKOS Corp (GKOS)'s trailing twelve month Return on Assets (ROA) is -19.72% as of 2026-06-30.
What is GKOS's ROIC (return on invested capital)?
GLAUKOS Corp (GKOS)'s trailing twelve month Return on Invested Capital (ROIC) is -27.28% as of 2026-06-30.
What is GKOS's EV/EBITDA?
GLAUKOS Corp (GKOS)'s trailing twelve month EV/EBITDA is -44.92x as of 2026-06-30.